OIG yields 526.18% · JNJ yields 2.13%● Live data
📍 OIG pulled ahead of the other in Year 1
Combined, OIG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OIG + JNJ for your $10,000?
Orbital Infrastructure Group, Inc. provides engineering, design, construction, and maintenance services to customers in the electric power, telecommunications, and renewable industries. It designs, installs, upgrades, repairs, and maintains electric power transmission and distribution infrastructure, and substation facilities, as well as offers emergency restoration services; and provides drilled shaft foundation construction services to the electric transmission and substation, industrial, telecommunication, and disaster restoration market sectors. The company also offers engineering, design, construction, and maintenance services to the broadband and wireless telecommunication industries; enterprise solutions to the cable and telecommunication industries; and telecommunication services, such as various wireless service capabilities. In addition, it provides engineering, procurement, and construction services that support the development of renewable energy generation focused on utility-scale solar construction. The company was formerly known as Orbital Energy Group, Inc. and changed its name to Orbital Infrastructure Group, Inc. in August 2022. Orbital Infrastructure Group, Inc. was incorporated in 1998 and is headquartered in Houston, Texas.
Full OIG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.